Biotech Stocks Muddled by Macro and Momentum is Missing…Update-2 rally day
Update-2... 6/27 2p EDT...Good day for gene therapy stocks My longs CRSP and MGTX are up. Looking better all across the screen in biopharma. Added to ABBV and XNCR yesterday. XBI up but still under $86. Update-1... Another Big Deal in Biotech in a weak biopharma sector Stock picking more...
M&A Makes A Rally Day in Biotech-Risk On…Update-3
Update-3. Red screen day, post after close, macro intervening again. BMY/CELG delayed on Otezla divestiture. Update -2 ...Week Ending 6/21-Biotech stocks up for the week but momentum easing. XBI up 1.2% to $87.26, off Wednesday highs. IBB up .2.2% to $109.45 QQQ up 1.6% to $188.62. Gene Therapy...
Biotech Snapshot on a Lackluster Day: CRSPR deal with Vertex Pharmaceuticals…Update-3…Pfizer Buys Array Pharmaceuticals
Update-3 6/17 11:30 a EDT Pfizer (PFE) $11B Buyout of Array Pharmaceuticals (ARRY) Sparks Rally in biotech. As usual M&A brings buyers into biotech. ARRY up 56% on Pfizer $11B buyout. XBI up 3.68% to $84.46. Green screen in mid-caps, gene therapy. ========== Update-2 6/12 10:30 a EDT Large...
Biotechs Piggyback FED Rally with a Little Help From ASCO…Update-3 Rally Underway
Update-3...6/7- 1p EDT... Broad Tech Rally Underway Hot stocks in life science: CRSP, GILD, GSK, ILMN, VRTX, XBI up 1.56%. Update-2 ...Bit of a rally at the close on the day-to-day tariff drama- now softening on Mexican tariffs; way too much obsession and media chat with the FED and rate cuts...
Biotechs Mixed Almost Bearish with Many Big Losers Today…Update-2 Red Screen Day
Update-2 5/31 2:15 p EDT. Impossible to invest with current Tariff Headwinds-XBI down 1.24% to $79.83. NASDAQ down 1.33%. ========= Update-1 5/29... Better Tape Today Off Lows Despite 1.1% Drop in IBB and 0.93% in XBI One of our top picks from JPM was Amarin (AMRN) up 11.64% to $19 on FDA Fast...